1. Mavrilimumab, a Fully Human Granulocyte–Macrophage Colony‐Stimulating Factor Receptor α Monoclonal Antibody: Long‐Term Safety and Efficacy in Patients With Rheumatoid Arthritis. Issue 5 (31st March 2018) Authors: Burmester, Gerd R.; McInnes, Iain B.; Kremer, Joel M.; Miranda, Pedro; Vencovský, Jiří; Godwood, Alex; Albulescu, Marius; Michaels, M. Alex; Guo, Xiang; Close, David; Weinblatt, Michael Journal: Arthritis & rheumatology Issue: Volume 70:Issue 5(2018) Page Start: 679 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗